United States

People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

22 Sep 2017
Change (% chg)

$0.05 (+0.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Williams, Peter 

Mr. Peter J. Williams is Vice President - Business Development of the Company. He joined ImmunoGen in August 2009, and has served as our Vice President, Business Development since that date. Prior to joining ImmunoGen, he served as a Senior Director of Business Development at Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, from 2006 to August 2009.

Basic Compensation

Total Annual Compensation, USD 266,694
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 359,822
Fiscal Year Total, USD 626,516

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --